Results 231 to 240 of about 296,469 (371)

Consideration of ledipasvir/sofosbuvir as an alternative to glecaprevir/pibrentasvir based upon on-treatment FIB-4 changes and sustained virologic response at 12 weeks in hepatitis C genotype 1 and 2 infections: A propensity score-matched study. [PDF]

Medicine (Baltimore)
Park HJ, Wang H, Jeong J, Seo KI, Shin JW, Park NH.   +5 more
europepmc   +1 more source

Long-term Follow-up of Hepatitis C Patients Who Achieved Sustained Virologic Response in the Pragmatic PRIORITIZE Study. [PDF]

Clin Gastroenterol Hepatol, 2023
Lok AS, Moon J, Sherman KE, Khalili M, Fishbein D, Reddy KR, PRIORITIZE Study Team.   +6 more
europepmc   +1 more source

Impact of sustained virologic response on risk of type 2 diabetes among hepatitis C patients in the United States

Journal of Viral Hepatitis, 2018
J. Li, T. Zhang, S. Gordon, L. Rupp, S. Trudeau, S. Holmberg, A. Moorman, P. Spradling, E. Teshale, J. Boscarino, M. Schmidt, Y. Daida, M. Lu, J. Xing, Yuna Zhong, D. Nerenz, L. Lamerato, N. Akkerman, Nancy Oja‐Tebbe, Yueren Zhou, Zahra Daar, Robert E Smith, Connie M. Trinacty, Carmen P Wong, Judy L. Donald   +24 more
semanticscholar   +1 more source

Retreatment of Direct Acting Agents (DAAs) After Initial DAA Failure in Hepatitis C Patients

Hepatology Research, EarlyView.
ABSTRACT Background and Aims Glecaprevir/pibrentasvir (GLE/PIB) and sofosbuvir/ledipasvir (SOF/LDV) are widely used as first‐line direct‐acting antiviral (DAA) regimens for chronic hepatitis C, achieving high virus eradication rates. However, a small proportion of patients experience treatment failure, and the optimal retreatment strategies for such ...
Nobuharu Tamaki, Masayuki Kurosaki, Hironori Ochi, Hideki Fujii, Yuichiro Suzuki, Takuya Sho, Hayato Hikita, Hiroyuki Marusawa, Yasuhiro Asahina, Namiki Izumi, Tatsuya Kanto   +10 more
wiley   +1 more source

High Sustained Virologic Response Rates of Glecaprevir/Pibrentasvir in Patients With Dosing Interruption or Suboptimal Adherence. [PDF]

Am J Gastroenterol, 2021
Zamor PJ, Brown A, Dylla DE, Dillon JF, Luetkemeyer AF, Feld JJ, Mutimer D, Ghalib R, Crown E, Lovell SS, Hu Y, Moreno C, Nelson DR, Colombo M, Papatheodoridis G, Rockstroh JK, Skoien R, Lawitz E, Jacobson IM.   +18 more
europepmc   +1 more source

Exploring the impact of baseline and on‐treatment variables on durability of responses to fostemsavir through weeks 96 and 192 in the phase 3 BRIGHTE study

HIV Medicine, EarlyView.
Abstract Objectives The gp120‐directed attachment inhibitor fostemsavir was effective in people with multidrug‐resistant (MDR) HIV‐1 in the BRIGHTE study. Understanding factors associated with virologic response can help clinicians optimize treatment and identify individuals for fostemsavir‐based regimens.
M. Gartland, X. Wang, Q. Liao, B. Li, F. Du, M. Krystal, A. R. Tenorio, A. Pierce, J. R. Castillo‐Mancilla   +8 more
wiley   +1 more source

Optimizing Hepatitis C Treatment Monitoring: Is Sustained Virologic Response at 4 Weeks Becoming the New Standard? [PDF]

Microorganisms
Milošević I, Filipović A, Beronja B, Mitrović N, Ružić M, Simić J, Knežević N, Pete M, Todorović N, Nikolić N.   +9 more
europepmc   +1 more source

Liver stiffness-based score at sustained virologic response predicts liver-related complications after eradication of hepatitis C virus. [PDF]

Kaohsiung J Med Sci, 2022
Kuo YH, Kee KM, Hung CH, Lu SN, Hu TH, Chen CH, Wang JH.   +6 more
europepmc   +1 more source

Sustained Virological Response as a Surrogate Marker for Mortality, Decompensated Cirrhosis, or Hepatocellular Carcinoma in People With Chronic Hepatitis C Virus Infection Treated With Direct-Acting Antivirals: Protocol for a Bayesian and Causal Mediation Analysis

Kurinchi Selvan Gurusamy, Christian Gluud   +1 more
openalex   +1 more source

Effectiveness of Ledipasvir-Sofosbuvir Combination in Patients With Hepatitis C Virus Infection and Factors Associated With Sustained Virologic Response.

Gastroenterology, 2016
N. Terrault, S. Zeuzem, A. D. Di Bisceglie, Joseph K. Lim, P. Pockros, Lynn M. Frazier, A. Kuo, A. Lok, M. Shiffman, Z. Ben Ari, L. Akushevich, Monika Vainorius, M. Sulkowski, M. Fried, D. Nelson   +14 more
semanticscholar   +1 more source